GLP-1 Market
LLY $1149.85 ▼ -0.6% NVO $37.40 ▼ -1.3% PFE $28.12 ▼ -1.4% VKTX $30.51 ▼ -6.4% KLRA $11.03 ▼ -3.4% GPCR $28.98 ▼ -7.3% RHHBY $52.35 ▲ +0.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Oxaliplatin

Company
National Cancer Institute (NCI)
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
82 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

82 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 2, 2026

Find a Clinical Trial Near Me

See recruiting studies for Oxaliplatin and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02889666

    A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer

    Not yet reported Shanghai Jiao Tong University School of Medicine 500 participants Est. completion 2027-12 3 sites Stand-alone
    Other conditions: Recurrent Non-small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT03125980

    Perioperative Versus Postoperative CapOX Chemotherapy for Locally Advanced Colon Cancer

    Not yet reported Fudan University 1370 participants Est. completion 2027-05 1 site Stand-alone
    Other conditions: Locally Advanced Colon Cancer
    View official trial listing →
  • Recruiting NCT NCT03418038

    Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia

    Not yet reported Mayo Clinic 80 participants Est. completion 2033-11-02 4 sites Stand-alone
    Other conditions: Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Lymphoma, Refractory Diffuse Large B-Cell Lymphoma, Refractory Lymphoma, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Recruiting NCT NCT03692429

    alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

    Not yet reported Celyad Oncology SA 49 participants Est. completion 2036-02-17 4 sites Stand-alone
    Other conditions: Unresectable Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT04120701

    CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II

    Not yet reported Centre Hospitalier Universitaire Dijon 1980 participants Est. completion 2032-03 1 site Stand-alone
    Other conditions: Patients With Resected Stage II Colon Cancer
    View official trial listing →
  • Recruiting NCT NCT04150640

    Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma

    Not yet reported University of Wisconsin, Madison 52 participants Est. completion 2028-05 1 site Stand-alone
    Other conditions: Esophageal Adenocarcinoma, Gastric Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT04276857

    Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic Cancer

    Not yet reported University of Saskatchewan 27 participants Est. completion 2026-12-31 2 sites
    Other conditions: Locally Advanced Pancreatic Cancer, Irreversible Electroporation
    View official trial listing →
  • Recruiting NCT NCT04329494

    PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

    Not yet reported City of Hope Medical Center 49 participants Est. completion 2028-01-05 3 sites Stand-alone
    Other conditions: Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8, Malignant Uterine Neoplasm, Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Gastric Carcinoma, Metastatic Malignant Neoplasm in the Peritoneum, Metastatic Malignant Solid Neoplasm, Metastatic Ovarian Carcinoma, Pathologic Stage IV Gastric Cancer AJCC v8, Peritoneal Carcinomatosis, Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8, Stage IV Appendix Carcinoma AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Uterine Corpus Cancer AJCC v8, Stage IVA Appendix Carcinoma AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVA Uterine Corpus Cancer AJCC v8, Stage IVB Appendix Carcinoma AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8, Stage IVB Uterine Corpus Cancer AJCC v8, Stage IVC Appendix Carcinoma AJCC v8, Stage IVC Colorectal Cancer AJCC v8
    View official trial listing →
  • Recruiting NCT NCT04516681

    Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

    Not yet reported Fudan University 400 participants Est. completion 2025-12-01 1 site Stand-alone
    Other conditions: Colorectal Cancer, Vitamin C, GLUT3
    View official trial listing →
  • Recruiting NCT NCT04844866

    Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

    Not yet reported Miltenyi Biomedicine GmbH 213 participants Est. completion 2031-09-30 51 sites
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04847063

    Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

    Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2034-12-30 1 site Stand-alone
    Other conditions: Peritoneal Mesothelioma, Peritoneal Carcinomatosis, Ovarian Cancer, Gastrointestinal Cancer, Appendiceal Cancer, Atypical Mesothelial Proliferation, Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT04926467

    Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

    Not yet reported Baylor Research Institute 24 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT04991948

    Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

    Not yet reported Celyad Oncology SA 34 participants Est. completion 2038-05-25 5 sites Stand-alone
    Other conditions: Unresectable Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT05067283

    A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

    Not yet reported Merck Sharp & Dohme LLC 830 participants Est. completion 2030-02-25 75 sites Stand-alone
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05228431

    Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer

    Not yet reported Zhen-Hai Lu 121 participants Est. completion 2028-05-01 1 site Stand-alone
    Other conditions: Advanced Rectal Cancer
    View official trial listing →
  • Recruiting NCT NCT05342194

    Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

    Not yet reported Shanghai Junshi Bioscience Co., Ltd. 480 participants Est. completion 2027-05-31 1 site Stand-alone
    Other conditions: Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Recruiting NCT NCT05424692

    Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer

    Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2027-09-01 1 site Stand-alone
    Other conditions: Colon Cancer, Rectal Cancer, Chemotherapy Effect, PTC, Exon Mutation
    View official trial listing →
  • Recruiting NCT NCT05476432

    HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study

    Not yet reported Sun Yat-sen University 300 participants Est. completion 2026-10-01 3 sites Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05624138

    The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy

    Not yet reported Tanta University 64 participants Est. completion 2025-06 1 site
    Other conditions: Neuropathy;Peripheral
    View official trial listing →
  • Recruiting NCT NCT05646511

    TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer

    Not yet reported National Cancer Center Hospital East 608 participants Est. completion 2030-12-31 34 sites Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Recruiting NCT NCT05713994

    Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma

    Ze-yang Ding, MD 300 participants Est. completion 2025-12-30 2 sites
    Other conditions: Hepatocellular Carcinoma Non-resectable
    View official trial listing →
  • Recruiting NCT NCT05719558

    A Study of ASP1002 in Adults for Treatment of Solid Tumors

    Not yet reported Astellas Pharma Global Development, Inc. 798 participants Est. completion 2030-05-31 15 sites Stand-alone
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT05727163

    FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients

    Not yet reported Sun Yat-sen University 194 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Recruiting NCT NCT05825066

    Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

    Not yet reported Wake Forest University Health Sciences 64 participants Est. completion 2028-07 2 sites Stand-alone
    Other conditions: Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT05859750

    A Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer

    Not yet reported Akeso 78 participants Est. completion 2025-12 7 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT05972655

    Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer

    Not yet reported Sir Run Run Shaw Hospital 32 participants Est. completion 2026-05-01 1 site Stand-alone
    Other conditions: Low Rectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06023758

    Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC

    Not yet reported Peking University 18 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: HER2-positive Locally Advanced Resectable Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT06048484

    Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

    Not yet reported Gulam Manji 60 participants Est. completion 2027-04 5 sites Stand-alone
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06054906

    Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer

    Not yet reported Huashan Hospital 50 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT06091423

    XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter Study

    Not yet reported Xiaofeng Chen 43 participants Est. completion 2026-11-25 1 site Stand-alone
    Other conditions: Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06121700

    Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer

    Not yet reported Fudan University 55 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Adenocarcinoma, Stomach Neoplasm, Gastroesophageal-junction Cancer, Oligometastatic Disease, Metastatic Cancer, Metastatic Gastric Cancer, Adenocarcinoma of the Stomach, Gastroesophageal Junction Adenocarcinoma, Metastatic Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06154538

    Immune Checkpoint Inhibitors + Chemotherapy Versus Chemotherapy in the Neoadjuvant Treatment of Locally Advanced Colorectal Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 170 participants Est. completion 2028-11-01 3 sites Stand-alone
    Other conditions: Locally Advanced Colorectal Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06208462

    Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 33 participants Est. completion 2027-01 3 sites Stand-alone
    Other conditions: Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06209099

    Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer

    Not yet reported Peking University Cancer Hospital & Institute 96 participants Est. completion 2025-11-01 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06212635

    Hemostasis in Liver Cirrhosis and Hepatocellular Cancer

    Region Stockholm 100 participants Est. completion 2028-12-01 1 site
    Other conditions: Hemostasis in Decompensated Liver Cirrhosis, Inflammation in Decompensated Liver Cirrhosis
    View official trial listing →
  • Recruiting NCT NCT06225843

    Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis

    Not yet reported Alethia Biotherapeutics 17 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06244225

    HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 38 participants Est. completion 2028-01-01 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06245356

    Safety of Trifluridine/Tipiracil in Patients With Dihydropyrimidine Dehydrogenase Deficiency Diagnosed With Metastatic Colorectal or Gastroesophageal Cancer

    Not yet reported UNICANCER 73 participants Est. completion 2028-10-21 21 sites
    Other conditions: Metastatic Colorectal Cancer, Metastatic Gastroesophageal Adenocarcinoma, DPD Deficiency
    View official trial listing →
  • Recruiting NCT NCT06278545

    Trial Evaluating Modified FOLFIRINOX and Modified FOLFOX in the Treatment of Locally Advanced or Metastatic Small Bowel Adenocarcinoma

    Not yet reported Centre Hospitalier Universitaire Dijon 130 participants Est. completion 2029-02 1 site Stand-alone
    Other conditions: Locally Advanced or Metastatic Small Bowel Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06363825

    A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular Carcinoma

    Not yet reported Fujian Medical University 57 participants Est. completion 2027-05-11 1 site Stand-alone
    Other conditions: Advanced Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06389760

    Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 57 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT06519578

    Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma

    Not yet reported RenJi Hospital 1115 participants Est. completion 2027-07-31 2 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06598007

    A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

    Not yet reported, Not yet reported Crossignal Therapeutics, Inc. 78 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06760858

    A Prospective Cohort Study on the Treatment of Locally Advanced Gastric Cancer

    Southwest Hospital, China 122 participants Est. completion 2029-09-01 2 sites
    Other conditions: Gastric Cancer, Gastroesophageal Junction Cancer
    View official trial listing →
  • Recruiting NCT NCT06793917

    Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

    Not yet reported Fujian Cancer Hospital 269 participants Est. completion 2029-04-01 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT06820463

    A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

    Not yet reported AbbVie 390 participants Est. completion 2028-04 75 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06835569

    A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

    Not yet reported Alterome Therapeutics, Inc. 448 participants Est. completion 2029-08 12 sites Stand-alone
    Other conditions: Cancer, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC (Non-small Cell Lung Cancer), CRC (Colorectal Cancer), Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT06839105

    A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

    Not yet reported Shanghai Junshi Bioscience Co., Ltd. 214 participants Est. completion 2028-04-30 13 sites Stand-alone
    Other conditions: Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT06852287

    Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 33 participants Est. completion 2026-09-01 1 site Stand-alone
    Other conditions: Intrahepatic Cholangiocarcinoma (Icc), Gall Bladder Cancer
    View official trial listing →
  • Recruiting NCT NCT06856447

    The Role of Coenzyme Q10 in the Prophylaxis of Oxaliplatin Induced Peripheral Neuropathy in Patients With Colorectal Cancer

    Not yet reported toqa saad mohammed mohammed 22 participants Est. completion 2026-01-10 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06881537

    CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer

    Not yet reported Shanghai Changzheng Hospital 15 participants Est. completion 2028-06-30 1 site Stand-alone
    Other conditions: Locally Recurrent Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT06896188

    9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY)

    Not yet reported Anwaar Saeed 12 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06951503

    AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer

    Not yet reported Akeso 560 participants Est. completion 2029-01-07 2 sites Stand-alone
    Other conditions: Colorectal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07030140

    Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

    Not yet reported Jinbo Yue 38 participants Est. completion 2028-01-01 1 site Stand-alone
    Other conditions: Cholangiocarcinoma, Hilar Cholangiocarcinoma, Bile Duct Cancer
    View official trial listing →
  • Recruiting NCT NCT07034742

    Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 136 participants Est. completion 2028-01-01 1 site Stand-alone
    Other conditions: Gastric Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07056010

    Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 30 participants Est. completion 2028-11-25 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Recruiting NCT NCT07059299

    A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma

    Not yet reported Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 18 participants Est. completion 2027-08 4 sites Stand-alone
    Other conditions: Esophagogastric Junction Adenocarcinoma, Gastric Adenocarcinoma, Esophageal Adenocarcinoma, Resectable Esophagogastric Adenocarcinoma, Neoadjuvant Therapy
    View official trial listing →
  • Recruiting NCT NCT07069712

    A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

    Not yet reported AstraZeneca 100 participants Est. completion 2029-07-16 70 sites Stand-alone
    Other conditions: Gastroesophageal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07070076

    A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma

    Not yet reported Li Qiang 286 participants Est. completion 2031-08-01 1 site
    Other conditions: Hepatocellular Carcinoma (HCC)
    View official trial listing →
  • Recruiting NCT NCT07108127

    Efficacy and Safety of Trastuzumab Biosimilars and Pertuzumab Biosimilars Combined With Chemotherapy for Neoadjuvant Treatment of Patients With Locally Advanced HER2-positive Rectal Cancer

    Not yet reported Peking Union Medical College Hospital 24 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Rectal Cancer, HER2-positive
    View official trial listing →
  • Recruiting NCT NCT07113275

    A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer

    Not yet reported Tao Zhang 444 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Rectal Cancer, Total Neoadjuvant Therapy, Radiotherapy, Immunotherapy
    View official trial listing →
  • Recruiting NCT NCT07132463

    Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study

    Not yet reported Fudan University 196 participants Est. completion 2030-12 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07201519

    Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

    Not yet reported Michael J Cavnar, MD 80 participants Est. completion 2030-02 1 site Stand-alone
    Other conditions: Colorectal Cancer Metastatic, Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07267806

    Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC

    Not yet reported Linhui Peng 326 participants Est. completion 2032-10 1 site Stand-alone
    Other conditions: Hepato Cellular Carcinoma (HCC), Chemotherapy Effect
    View official trial listing →
  • Recruiting NCT NCT07283367

    A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.

    Not yet reported, Not yet reported Hansoh BioMedical R&D Company 502 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: CRC
    View official trial listing →
  • Recruiting NCT NCT07291401

    Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC

    Not yet reported Zhongnan Hospital 108 participants Est. completion 2029-01-01 1 site Stand-alone
    Other conditions: Rectal Cancer Patients
    View official trial listing →
  • Recruiting NCT NCT07328087

    COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer

    Not yet reported Biogenea Pharmaceuticals Ltd. 12 participants Est. completion 2031-12-02 1 site Stand-alone
    Other conditions: Colorectal Cancer Metastatic, Colorectal Cancer Stage III, Colorectal Cancer Stage IV
    View official trial listing →
  • Recruiting NCT NCT07330271

    PTC-Guided Therapy for Peritoneal Mesothelioma

    Not yet reported Beijing Tsinghua Chang Gung Hospital 347 participants Est. completion 2031-11-01 1 site
    Other conditions: Peritoneal Mesothelioma
    View official trial listing →
  • Recruiting NCT NCT07337460

    Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

    Not yet reported Northern Jiangsu People's Hospital 30 participants Est. completion 2028-01-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma (HCC)
    View official trial listing →
  • Recruiting NCT NCT07365592

    Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC

    Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 138 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07384234

    SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis

    Not yet reported Ruijin Hospital 60 participants Est. completion 2030-12-30 2 sites Stand-alone
    Other conditions: Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07466238

    HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

    Not yet reported Peking University 40 participants Est. completion 2029-03-31 2 sites Stand-alone
    Other conditions: Biliary Tract Cancer (BTC)
    View official trial listing →
  • Recruiting NCT NCT07468630

    Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma

    Not yet reported Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 106 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Colon Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07474727

    A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

    Not yet reported Multitude Therapeutics Inc. 180 participants Est. completion 2028-02-28 19 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07503756

    JS212 Combination Therapies in Metastatic Colorectal Cancer

    Not yet reported Shanghai Junshi Bioscience Co., Ltd. 80 participants Est. completion 2028-03-30 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07527026

    A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer

    Not yet reported Chinese PLA General Hospital 44 participants Est. completion 2029-02-01 1 site Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07594340

    HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)

    Not yet reported Binkui Li 300 participants Est. completion 2030-05-30 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07653685

    A Clinical Trial Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Patients With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.

    Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 71 participants Est. completion 2028-12 31 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Recruiting NCT NCT07673887

    A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

    Not yet reported Astellas Pharma Global Development, Inc. 570 participants Est. completion 2031-02-28 3 sites Stand-alone
    Other conditions: Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07750951

    Single-arm, Phase II Clinical Study Evaluating the Safety and Efficacy of Sintilimab Combined With IBI-310 and Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer

    Not yet reported Xijing Hospital 34 participants Est. completion 2027-04 1 site Stand-alone
    Other conditions: MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT07790510

    HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Haisco Pharmaceutical Group Co., Ltd. 180 participants Est. completion 2030-09-30 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer (CRC)
    View official trial listing →
  • Recruiting NCT NCT07809893

    Ivosidenib Plus mFOLFOXIRI and Celecoxib for BRAF-targeted Therapy-refractory BRAF V600E-mutant Colorectal Cancer Patients

    Not yet reported Sun Yat-sen University 45 participants Est. completion 2028-06-30 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00001835

    Oxaliplatin in Cancer Patients With Impaired Kidney Function

    Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2001-12 1 site
    Other conditions: Kidney Disease, Neoplasm, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT00005036

    Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) 560 participants 1 site Stand-alone
    Other conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Recurrent Colon Cancer, Recurrent Rectal Cancer, Signet Ring Adenocarcinoma of the Colon, Signet Ring Adenocarcinoma of the Rectum, Stage IIIA Colon Cancer, Stage IIIA Rectal Cancer, Stage IIIB Colon Cancer, Stage IIIB Rectal Cancer, Stage IIIC Colon Cancer, Stage IIIC Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT00005856

    Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

    Not yet reported, Not yet reported National Cancer Institute (NCI) 59 participants 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma
    View official trial listing →
  • Status unknown NCT NCT00006117

    Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 10 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00025142

    Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

    Not yet reported Stanford University Est. completion 2006-11 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00034619

    A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.

    Not yet reported Eli Lilly and Company 22 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00039611

    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) Est. completion 2007-10 19 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00043121

    Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery

    Not yet reported National Cancer Institute (NCI) 50 participants 1 site Stand-alone
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00047177

    Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

    Not yet reported Pediatric Brain Tumor Consortium 43 participants Est. completion 2007-07 10 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00052364

    Oxaliplatin in Treating Patients With Liver Cancer

    Not yet reported National Cancer Institute (NCI) 32 participants 1 site Stand-alone
    Other conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    View official trial listing →
  • Completed NCT NCT00061815

    Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

    Not yet reported Eli Lilly and Company 102 participants Est. completion 2005-11 39 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00066274

    Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported UNICANCER Est. completion 2007-04-01 17 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00070265

    Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer

    Not yet reported National Cancer Institute (NCI) 80 participants 1 site Stand-alone
    Other conditions: Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00071929

    Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer

    Not yet reported Gynecologic Oncology Group Est. completion 2007-09 38 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT00074321

    Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors

    Not yet reported National Cancer Institute (NCI) 84 participants 1 site Stand-alone
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Status unknown NCT NCT00075543

    Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

    Not yet reported, Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 5 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Terminated NCT NCT00077233

    FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum

    Not yet reported Alliance for Clinical Trials in Oncology 238 participants Est. completion 2010-06 77 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00081289

    Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer

    Not yet reported Radiation Therapy Oncology Group 146 participants Est. completion 2016-12 5 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00086983

    Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors

    Not yet reported National Cancer Institute (NCI) 15 participants 1 site Stand-alone
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00112528

    Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 53 participants Est. completion 2010-11 201 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00112996

    Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer

    Not yet reported M.D. Anderson Cancer Center 244 participants Est. completion 2014-04 13 sites
    Other conditions: Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00127036

    Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 65 participants Est. completion 2010-12 12 sites Stand-alone
    Other conditions: Adenocarcinoma, Colon Cancer
    View official trial listing →
  • Completed NCT NCT00142467

    Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

    Not yet reported Massachusetts General Hospital 33 participants Est. completion 2011-06 3 sites Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT00177307

    Safety and Efficacy Study Using Bevacizumab, Capecitabine and Oxaliplatin for Colorectal Cancer

    Not yet reported University of Pittsburgh 40 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT00191568

    Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer

    Not yet reported Eli Lilly and Company 45 participants Est. completion 2007-05 6 sites
    Other conditions: Pancreatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00192075

    A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer

    Not yet reported Eli Lilly and Company 84 participants Est. completion 2007-11 15 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00193609

    Oxaliplatin and Capecitabine in the Treatment of Relapsed/Refractory Carcinoma of Unknown Primary Site

    Not yet reported SCRI Development Innovations, LLC 48 participants Est. completion 2009-01 10 sites Stand-alone
    Other conditions: Neoplasms, Unknown Primary
    View official trial listing →
  • Completed NCT NCT00200200

    Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 73 participants Est. completion 2025-03-13 5 sites
    Other conditions: Hepatic Metastases, Colon Cancer, Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT00226941

    A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer

    Not yet reported, Not yet reported George Albert Fisher 23 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: Rectal Cancer, Colo-rectal Cancer
    View official trial listing →
  • Completed NCT NCT00250029

    Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen

    Not yet reported New Mexico Cancer Research Alliance 30 participants Est. completion 2006-03 4 sites
    Other conditions: Colonic Diseases, Cancer
    View official trial listing →
  • Completed NCT NCT00262808

    GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer

    Not yet reported University of Rochester 50 participants Est. completion 2006-09 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00268398

    Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 284 participants 32 sites Stand-alone
    Other conditions: Colorectal Cancer, Metastatic Cancer, Chemotherapy
    View official trial listing →
  • Status unknown NCT NCT00275119

    Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

    Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 11 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00275210

    MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer

    Not yet reported Sanofi 2246 participants Est. completion 2003-04 19 sites
    Other conditions: Colonic Neoplasms
    View official trial listing →
  • Completed NCT NCT00280618

    Oxaliplatin in Unresectable Hepatocellular Carcinoma

    Not yet reported Sanofi
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Completed NCT NCT00305786

    Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

    Not yet reported University of Miami 30 participants Est. completion 2010-05 2 sites
    Other conditions: Lung Cancer
    View official trial listing →
  • Terminated NCT NCT00335959

    S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery

    Not yet reported SWOG Cancer Research Network 7 participants 75 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00353262

    A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.

    Not yet reported Hoffmann-La Roche 36 participants Est. completion 2008-04 3 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00353457

    Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma

    Not yet reported Abramson Cancer Center at Penn Medicine 6 participants Est. completion 2011-06 Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT00356941

    Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC

    Not yet reported Masonic Cancer Center, University of Minnesota 4 participants Est. completion 2007-05 1 site Stand-alone
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00381706

    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 245 participants Est. completion 2014-10-15 227 sites Stand-alone
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT00382720

    Docetaxel and Oxaliplatin in Gastric Cancer

    Not yet reported Sanofi 275 participants Est. completion 2010-04 12 sites Stand-alone
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Terminated NCT NCT00385021

    ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer

    Not yet reported Southwestern Regional Medical Center 20 participants Est. completion 2007-09 1 site
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT00393861

    Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients

    Not yet reported Indiana University 29 participants Est. completion 2014-11 2 sites Stand-alone
    Other conditions: Neoplasms, Germ Cell and Embryonal
    View official trial listing →
  • Terminated NCT NCT00394992

    Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer

    Not yet reported Dutch Colorectal Cancer Group 79 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Colorectal Cancer, Liver Metastases
    View official trial listing →
  • Completed NCT NCT00398320

    Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors

    Not yet reported Pamela L. Kunz 40 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Status unknown NCT NCT00408551

    Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

    Not yet reported Goshen Health System 20 participants 1 site Stand-alone
    Other conditions: Colorectal Cancer, Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT00425841

    Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer

    Not yet reported Technical University of Munich 29 participants Est. completion 2009-12 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00427713

    Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer

    Not yet reported Cancer Research UK 800 participants 72 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00433550

    Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 33 participants Est. completion 2016-05 115 sites Stand-alone
    Other conditions: Small Intestine Adenocarcinoma, Recurrent Small Intestine Cancer
    View official trial listing →
  • Completed NCT NCT00436241

    A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.

    Not yet reported Hoffmann-La Roche 45 participants Est. completion 2010-11 13 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00436280

    Chemotherapy for Participants With Lymphoma

    Not yet reported Eli Lilly and Company 68 participants Est. completion 2012-11 18 sites Stand-alone
    Other conditions: Lymphoma, Large Cell, Diffuse
    View official trial listing →
  • Status unknown NCT NCT00453115

    Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

    Not yet reported National Cancer Center, Korea 43 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00454636

    A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.

    Not yet reported Hoffmann-La Roche 158 participants Est. completion 2010-07 51 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Terminated NCT NCT00470340

    Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients

    Not yet reported Assistance Publique - Hôpitaux de Paris 263 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Liver Neoplasms, Liver Cirrhosis, Carcinoma, Hepatocellular, Recurrence, Neoplasm Recurrence, Local
    View official trial listing →
  • Completed NCT NCT00502567

    A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors

    Not yet reported AstraZeneca 104 participants Est. completion 2011-06 3 sites
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Completed NCT NCT00503997

    Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 42 participants Est. completion 2010-06 7 sites Stand-alone
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT00511446

    Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer

    Not yet reported Martin-Luther-Universität Halle-Wittenberg 56 participants Est. completion 2013-01 10 sites Stand-alone
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Completed NCT NCT00512681

    A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer

    Not yet reported National Cancer Center, Korea 44 participants Est. completion 2009-07 1 site
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Completed NCT NCT00514020

    Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 33 participants Est. completion 2011-02 5 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00515216

    Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors

    Not yet reported Vanderbilt University 26 participants Est. completion 2013-11 4 sites Stand-alone
    Other conditions: Stomach Neoplasms, Esophageal Neoplasms
    View official trial listing →
  • Completed NCT NCT00525005

    Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer

    Not yet reported Hallym University Medical Center 44 participants Est. completion 2010-06 2 sites Stand-alone
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Completed NCT NCT00533533

    A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer

    Not yet reported, Not yet reported Samsung Medical Center 68 participants Est. completion 2008-06 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00536809

    Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer

    Not yet reported GlaxoSmithKline 12 participants Est. completion 2008-10-31 1 site Stand-alone
    Other conditions: Neoplasms, Colorectal
    View official trial listing →
  • Terminated NCT NCT00541112

    Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

    Not yet reported UNICANCER 19 participants Est. completion 2010-01-29 10 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Suspended NCT NCT00568529

    Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

    Not yet reported Fudan University 30 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT00587145

    Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer

    Not yet reported National Cancer Center, Korea 44 participants Est. completion 2009-05 1 site
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Terminated NCT NCT00588900

    Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab

    Not yet reported Alliance for Clinical Trials in Oncology 5 participants Est. completion 2011-11 31 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00602602

    Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 19 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00623805

    A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 123 participants Est. completion 2012-05 10 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00631410

    Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer

    Not yet reported Pfizer 12 participants Est. completion 2010-03 3 sites
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Terminated NCT NCT00636883

    Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer

    Not yet reported National Guard Health Affairs 9 participants Est. completion 2012-07 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT00690300

    Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer

    Not yet reported University of Ulm 44 participants Est. completion 2010-12 5 sites
    Other conditions: Pancreas Neoplasms
    View official trial listing →
  • Completed NCT NCT00700570

    A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 45 participants Est. completion 2011-11 6 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00720512

    Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab

    Not yet reported Gruppo Oncologico del Nord-Ovest 184 participants Est. completion 2014-03 21 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT00728000

    Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma

    Not yet reported University of Cincinnati Est. completion 2010-08 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Terminated NCT NCT00777192

    Longitudinal Study of Symptoms in Colorectal Cancer

    M.D. Anderson Cancer Center 509 participants Est. completion 2018-12-27 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00779311

    A Phase I Trial Evaluating mFOLFOX6 and Avastin With Nexavar as First-Line Treatment for Metastatic Colorectal Cancer

    Not yet reported Accelerated Community Oncology Research Network 8 participants Est. completion 2011-03 3 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00785122

    IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)

    Not yet reported, Not yet reported Immatics Biotechnologies GmbH 92 participants Est. completion 2013-05 41 sites
    Other conditions: Colorectal Carcinoma
    View official trial listing →
  • Completed NCT NCT00790816

    Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

    Not yet reported Novartis Pharmaceuticals 500 participants Est. completion 2016-08-19 23 sites Stand-alone
    Other conditions: Neoplasms, Breast
    View official trial listing →
  • Completed NCT NCT00831181

    Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer

    Not yet reported Beth Israel Medical Center 27 participants Est. completion 2009-11 2 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00845039

    A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab

    Not yet reported Eli Lilly and Company 4 participants Est. completion 2011-02 3 sites
    Other conditions: Colon Cancer, Rectal Cancer
    View official trial listing →
  • Completed NCT NCT00849550

    Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.

    Not yet reported Herbert Hurwitz 32 participants Est. completion 2012-12 3 sites Stand-alone
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific, Cancer
    View official trial listing →
  • Completed NCT NCT00849615

    Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

    Not yet reported Krankenhaus Nordwest 252 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction
    View official trial listing →
  • Status unknown NCT NCT00854971

    Efficacy Study of TKcell in Advanced Colorectal Cancer

    Not yet reported, Not yet reported Binex 86 participants Est. completion 2010-01 1 site
    Other conditions: Advanced Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00859469

    Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma

    Not yet reported Columbia University 29 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Mesothelioma
    View official trial listing →
  • Completed NCT NCT00865709

    Study of Modified FOLFOX6 Plus or Minus Sorafenib in Stage IV Metastatic Colorectal Carcinoma (mCRC) Subjects

    Not yet reported Bayer 198 participants Est. completion 2012-02 116 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00869271

    Postoperative Folfox4 Only Versus Folfox4 Plus Transhepatic Arterial Chemotherapy (TAC) in the Treatment Unresectable Liver Metastasis of Colorectal Cancer

    Not yet reported Fudan University 200 participants Est. completion 2007-12 1 site Stand-alone
    Other conditions: Unresectable Liver Metastasis of Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00881504

    A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma

    Not yet reported Georgetown University 9 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Completed NCT NCT00920868

    XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib

    Not yet reported Herbert Hurwitz, MD 22 participants Est. completion 2014-08 2 sites Stand-alone
    Other conditions: Solid Tumor, Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00940303

    OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 97 participants Est. completion 2014-02 17 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT00954005

    Study With Rituximab-Gemcitabine/Oxaliplatin in Relapsed Indolent Lymphoma

    Not yet reported, Not yet reported German Low Grade Lymphoma Study Group 56 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Indolent Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT00954876

    Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

    Not yet reported Translational Genomics Research Institute Est. completion 2010-01 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00957905

    Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors

    Not yet reported National Cancer Institute (NCI) 36 participants Est. completion 2014-08 10 sites Stand-alone
    Other conditions: Recurrent Extragonadal Seminoma, Recurrent Malignant Extragonadal Germ Cell Tumor, Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell Tumor, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Ovarian Germ Cell Tumor, Stage III Testicular Cancer, Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor, Stage IV Extragonadal Seminoma, Stage IV Ovarian Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00959647

    A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

    Not yet reported Genentech, Inc. 19 participants Est. completion 2014-01-09 10 sites Stand-alone
    Other conditions: Ovarian Cancer, Basal Cell Carcinoma, Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00973609

    Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC)

    Not yet reported AIO-Studien-gGmbH 853 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01019863

    Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma.

    Not yet reported Centre de recherche du Centre hospitalier universitaire de Sherbrooke 50 participants Est. completion 2011-10 2 sites Stand-alone
    Other conditions: Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01048320

    Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer

    Not yet reported Royal Marsden NHS Foundation Trust 36 participants Est. completion 2010-12 1 site
    Other conditions: Advanced Pancreatic Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT01061515

    Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer

    Not yet reported Washington University School of Medicine 21 participants Est. completion 2027-09-27 1 site Stand-alone
    Other conditions: Carcinoma
    View official trial listing →
  • Completed NCT NCT01071655

    Selecting Treatment in Colorectal Cancer:Capecitabine or 5-fluorouracil Selection to be Combined With Oxaliplatin or Irinotecan as First-line Chemotherapy in Advanced Colorectal Cancer

    Not yet reported Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 195 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01080547

    Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer

    Not yet reported Zhejiang University 374 participants Est. completion 2014-12 2 sites
    Other conditions: Length of Stay, Complications, Adverse Drug Event, Quality of Life, Hospital Costs
    View official trial listing →
  • Status unknown NCT NCT01092481

    Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

    Not yet reported Samsung Medical Center 1580 participants Est. completion 2019-12 17 sites Stand-alone
    Other conditions: Colon Cancer
    View official trial listing →
  • Status unknown NCT NCT01100801

    A Study of Genomic-guided 'Standard-of-care' Chemotherapy for in Advanced Gastric Cancer Patients

    Not yet reported National University Hospital, Singapore 90 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Recurrent Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01108107

    Neoadjuvant Treatment of Colon Cancer

    Not yet reported Vejle Hospital 76 participants Est. completion 2015-03 3 sites
    Other conditions: Colon Cancer
    View official trial listing →
  • Status unknown NCT NCT01125020

    Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation

    Not yet reported Shanghai Jiao Tong University School of Medicine 150 participants Est. completion 2010-12 1 site
    Other conditions: Liver Transplantation, Hepatocellular Carcinoma, Tumor Recurrence and Metastasis, Survival, Adjuvant Chemotherapy
    View official trial listing →
  • Completed NCT NCT01163396

    First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer

    Not yet reported Gruppo Oncologico del Nord-Ovest 57 participants Est. completion 2010-04 Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT01178944

    Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer

    Not yet reported Roswell Park Cancer Institute 35 participants Est. completion 2015-11 2 sites Stand-alone
    Other conditions: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Undifferentiated Carcinoma, Gastric Adenocarcinoma, Gastric Squamous Cell Carcinoma, Recurrent Esophageal Adenocarcinoma, Recurrent Esophageal Squamous Cell Carcinoma, Recurrent Gastric Carcinoma, Stage IIIB Esophageal Adenocarcinoma, Stage IIIB Esophageal Squamous Cell Carcinoma, Stage IIIB Gastric Cancer, Stage IIIC Esophageal Adenocarcinoma, Stage IIIC Esophageal Squamous Cell Carcinoma, Stage IIIC Gastric Cancer, Stage IV Esophageal Adenocarcinoma, Stage IV Esophageal Squamous Cell Carcinoma, Stage IV Gastric Cancer, Undifferentiated Gastric Carcinoma
    View official trial listing →
  • Completed NCT NCT01202409

    CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater

    Not yet reported M.D. Anderson Cancer Center 19 participants Est. completion 2018-07-03 1 site
    Other conditions: Gastrointestinal Cancer
    View official trial listing →
  • Completed NCT NCT01206530

    FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

    Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 50 participants Est. completion 2017-09 1 site
    Other conditions: Rectal Cancer, Colon Cancer, Metastasis, Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01222312

    Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel

    Not yet reported Krankenhaus Nordwest 88 participants Est. completion 2011-11 1 site Stand-alone
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01226719

    FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

    Not yet reported SCRI Development Innovations, LLC 15 participants Est. completion 2014-03 15 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT01227239

    Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting

    Not yet reported, Not yet reported Japan Clinical Cancer Research Organization 45 participants Est. completion 2016-08 6 sites Stand-alone
    Other conditions: Rectal Carcinoma
    View official trial listing →
  • Terminated NCT NCT01229111

    Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

    Not yet reported National Cancer Institute (NCI) 14 participants Est. completion 2014-03 7 sites Stand-alone
    Other conditions: Adult Primary Cholangiocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Extrahepatic Bile Duct, Cholangiocarcinoma of the Gallbladder, Localized Unresectable Adult Primary Liver Cancer, Periampullary Adenocarcinoma, Recurrent Adult Primary Liver Cancer, Recurrent Extrahepatic Bile Duct Cancer, Recurrent Gallbladder Cancer, Unresectable Extrahepatic Bile Duct Cancer, Unresectable Gallbladder Cancer
    View official trial listing →
  • Withdrawn NCT NCT01245582

    Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients

    Not yet reported Sanofi Est. completion 2015-08 Stand-alone
    Other conditions: Hepatic Neoplasm Malignant
    View official trial listing →
  • Completed NCT NCT01246960

    A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

    Not yet reported Eli Lilly and Company 168 participants Est. completion 2014-05 58 sites Stand-alone
    Other conditions: Stomach Cancer, Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT01295086

    Taxotere®, Eloxatin® and Xeloda® (TEX) in Combination With Herceptin® as Treatment for HER2 Positive Non-resectable Cancer

    Not yet reported Odense University Hospital 27 participants Est. completion 2018-01 4 sites Stand-alone
    Other conditions: Adenocarcinoma
    View official trial listing →
  • Terminated NCT NCT01307956

    Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

    Not yet reported University of Nebraska 11 participants Est. completion 2015-12-23 1 site Stand-alone
    Other conditions: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Adenocarcinoma, Stage IIA Esophageal Cancer, Stage IIB Esophageal Cancer
    View official trial listing →
  • Terminated NCT NCT01320683

    Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer

    Not yet reported City of Hope Medical Center 1 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT01331928

    Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer

    Not yet reported Taipei Veterans General Hospital, Taiwan 51 participants 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01339832

    An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer

    Hoffmann-La Roche 51 participants Est. completion 2011-12 5 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01358812

    FOLFOXIRI Plus Panitumumab In Kras and Braf Wild-Type Metastatic Colorectal Cancer

    Not yet reported Gruppo Oncologico del Nord-Ovest 37 participants 10 sites Stand-alone
    Other conditions: Metastatic Colo-rectal Cancer
    View official trial listing →
  • Terminated NCT NCT01359007

    FOLFIRINOX in Patients With Inoperable Pancreatic Cancer

    Not yet reported University of Oklahoma 5 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Adenocarcinoma of Pancreas
    View official trial listing →
  • Completed NCT NCT01362361

    TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)

    Not yet reported Martin-Luther-Universität Halle-Wittenberg 54 participants Est. completion 2016-12 12 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT01403259

    SOX as Salvage Treatment in Nasopharyngeal Carcinoma

    Not yet reported Fudan University 16 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Nasopharyngeal Carcinoma
    View official trial listing →
  • Status unknown NCT NCT01429961

    Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma

    Not yet reported Seoul National University Hospital 38 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Advanced Hepatocellular Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT01460589

    Early Commencement of Adjuvant Chemotherapy for Colon Cancer

    Not yet reported Kyungpook National University Hospital 303 participants Est. completion 2026-12-28 2 sites Stand-alone
    Other conditions: Colon Cancer
    View official trial listing →
  • Status unknown NCT NCT01467921

    Study of LV5FU2 Versus FOLFOX for Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma

    Not yet reported Samsung Medical Center 68 participants 1 site Stand-alone
    Other conditions: Curatively-resected, Node-positive Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT01472601

    A Prospective Study of Pharmacogenetic Factors and Gene Expression Profile

    Samsung Medical Center 2660 participants Est. completion 2020-04 1 site
    Other conditions: Colon Cancer
    View official trial listing →
  • Completed NCT NCT01488552

    Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

    Not yet reported, Not yet reported Pancreatic Cancer Research Team 60 participants Est. completion 2016-08 5 sites Stand-alone
    Other conditions: Stage IV Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01490866

    A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC)

    Not yet reported SCRI Development Innovations, LLC 70 participants Est. completion 2015-07 12 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01503372

    FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer

    Not yet reported Charite University, Berlin, Germany 75 participants Est. completion 2017-12-14 1 site Stand-alone
    Other conditions: Advanced Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01516944

    Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

    Not yet reported, Not yet reported Hebei Medical University 749 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01524094

    Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis

    Not yet reported Uppsala University 49 participants Est. completion 2012-01 1 site
    Other conditions: Colorectal Peritoneal Carcinomatosis
    View official trial listing →
  • Terminated NCT NCT01525069

    Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma

    Not yet reported Washington University School of Medicine 27 participants Est. completion 2022-08-02 1 site Stand-alone
    Other conditions: Cholangiocarcinoma, Liver Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01542294

    SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer

    Not yet reported, Not yet reported Chinese Academy of Medical Sciences 71 participants Est. completion 2017-04 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT01552980

    Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma

    Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 30 participants Est. completion 2014-02 1 site
    Other conditions: Gastric Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01575730

    Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis

    Not yet reported University Hospital, Ghent 45 participants Est. completion 2013-03-18 1 site
    Other conditions: Peritoneal Carcinomatosis
    View official trial listing →
  • Completed NCT NCT01590719

    A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer

    Not yet reported Hoffmann-La Roche 123 participants Est. completion 2014-10 36 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01626664

    KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

    Not yet reported Kyowa Kirin, Inc. 71 participants Est. completion 2018-02 20 sites
    Other conditions: Adult T-cell Leukemia-Lymphoma
    View official trial listing →
  • Completed NCT NCT01660711

    A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

    Not yet reported Endeavor Health 22 participants Est. completion 2018-08-22 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT01662869

    A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer

    Not yet reported Hoffmann-La Roche 564 participants Est. completion 2015-12 125 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01677884

    Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 10 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT01740648

    Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer

    Not yet reported Ohio State University Comprehensive Cancer Center 19 participants Est. completion 2021-09-29 4 sites Stand-alone
    Other conditions: Recurrent Rectal Cancer, Stage IIA Rectal Cancer, Stage IIB Rectal Cancer, Stage IIC Rectal Cancer, Stage IIIA Rectal Cancer, Stage IIIB Rectal Cancer, Stage IIIC Rectal Cancer
    View official trial listing →
  • Completed NCT NCT01748773

    A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction Cancer

    Not yet reported Hoffmann-La Roche 34 participants Est. completion 2017-06-15 9 sites Stand-alone
    Other conditions: Gastric Cancer, Gastroesophageal Junction Cancer
    View official trial listing →
  • Terminated NCT NCT01760694

    Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer

    Not yet reported Southwestern Regional Medical Center 6 participants Est. completion 2014-07 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT01787539

    The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer

    Not yet reported, Not yet reported Medical University of Lublin 180 participants Est. completion 2022-02 2 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01827553

    Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

    Not yet reported University of Erlangen-Nürnberg Medical School 830 participants Est. completion 2023-11-08 23 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT01832948

    Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer

    Not yet reported Zhejiang Cancer Hospital 30 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT01843829

    A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer

    Not yet reported Lisette Nixon 85 participants Est. completion 2016-05 12 sites Stand-alone
    Other conditions: Oesophageal Cancer
    View official trial listing →
  • Terminated NCT NCT01858662

    Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 4 participants Est. completion 2015-11 7 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01882868

    A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan

    Not yet reported Sanofi 62 participants Est. completion 2015-08 19 sites
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT01896531

    A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer

    Not yet reported Genentech, Inc. 153 participants Est. completion 2021-01-26 34 sites Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01905150

    Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

    Not yet reported Bruckner Oncology 34 participants Est. completion 2020-01 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01942200

    A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of Cancer

    Onkovis GmbH 383 participants Est. completion 2018-07-25 3 sites
    Other conditions: Carcinoma
    View official trial listing →
  • Completed NCT NCT01959139

    S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

    Not yet reported, Not yet reported SWOG Cancer Research Network 126 participants Est. completion 2023-11-09 154 sites Stand-alone
    Other conditions: Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT01963702

    A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC

    Not yet reported Fudan University 120 participants Est. completion 2014-12 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT02022033

    BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

    Not yet reported Brown University 25 participants Est. completion 2022-03-17 2 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT02024191

    The Role of Glutamine for Preventing Oxaliplatin-Induced Peripheral Neuropathy

    Not yet reported Ankara Education and Research Hospital 80 participants Est. completion 2015-06 1 site
    Other conditions: Peripheral Neuropathy
    View official trial listing →
  • Completed NCT NCT02028806

    mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer

    Not yet reported Yuhong Li 40 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Metastatic Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT02042391

    Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy

    Not yet reported Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH 60 participants Est. completion 2022-07-13 18 sites Stand-alone
    Other conditions: Posttransplant Lymphoproliferative Disorder
    View official trial listing →
  • Completed NCT NCT02048540

    Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell

    Not yet reported, Not yet reported Chinese PLA General Hospital 86 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Locally Advanced Gastric Carcinoma
    View official trial listing →
  • Status unknown NCT NCT02087475

    Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

    Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 360 participants Est. completion 2024-12 1 site
    Other conditions: Colorectal Neoplasms, Effects of Chemotherapy, Surgery, Metastasis, Local Neoplasm Recurrence
    View official trial listing →
  • Status unknown NCT NCT02102789

    A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis

    Not yet reported Yuhong Li 142 participants Est. completion 2024-12 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT02105350

    A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer

    Not yet reported University Health Network, Toronto Est. completion 2015-06 Stand-alone
    Other conditions: Biliary Tract Carcinoma, Gallbladder Carcinoma
    View official trial listing →
  • Terminated NCT NCT02141295

    A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer

    Not yet reported Hoffmann-La Roche 197 participants Est. completion 2017-02-01 39 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT02193594

    Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric Adenocarcinoma

    Not yet reported, Not yet reported Peking University 214 participants Est. completion 2020-05 1 site Stand-alone
    Other conditions: Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02231723

    A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

    Not yet reported Sumitomo Pharma America, Inc. 139 participants Est. completion 2020-06 12 sites Stand-alone
    Other conditions: Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02244632

    Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer

    Not yet reported, Not yet reported Isofol Medical AB 105 participants Est. completion 2020-01-30 10 sites Stand-alone
    Other conditions: Colorectal Neoplasm
    View official trial listing →
  • Status unknown NCT NCT02250209

    T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy

    Not yet reported Chinese PLA General Hospital 40 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT02266355

    Role of Omalizumab in Reducing the Incidence of Oxaliplatin-induced Hypersensitivity Reaction

    Not yet reported Yale University 9 participants Est. completion 2018-02-27 1 site
    Other conditions: Colon Cancer
    View official trial listing →
  • Completed NCT NCT02284529

    Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer

    Not yet reported Sinphar Pharmaceutical Co., Ltd 20 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Stage-Ⅱ Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02287129

    Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction

    Not yet reported Technical University of Munich 75 participants Est. completion 2020-08-07 1 site Stand-alone
    Other conditions: Adenocarcinoma of the Esophagogastric Junction
    View official trial listing →
  • Completed NCT NCT02314182

    GRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable Metastasis

    Not yet reported Hospices Civils de Lyon 5 participants Est. completion 2018-02-27 3 sites
    Other conditions: Rectal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT02338518

    Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients

    Not yet reported Jinling Hospital, China 297 participants Est. completion 2023-10 1 site Stand-alone
    Other conditions: Stomach Neoplasms, Gastric Cancer
    View official trial listing →
  • Completed NCT NCT02340403

    Exploration by NMR Spectroscopy of the Choline Concentrations in the Insular Cortex of Patients Suffering of Neuropathic Pain Induced by Oxaliplatin

    Not yet reported University Hospital, Clermont-Ferrand 42 participants Est. completion 2021-08-27 1 site Stand-alone
    Other conditions: Neuropathy, Painful
    View official trial listing →
  • Terminated NCT NCT02345460

    Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study

    Not yet reported Case Comprehensive Cancer Center 1 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Pancreatic Adenocarcinoma, Poorly Differentiated Malignant Neoplasm, Resectable Pancreatic Cancer, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer, Stage IIA Pancreatic Cancer, Stage IIB Pancreatic Cancer, Stage III Pancreatic Cancer, Undifferentiated Pancreatic Carcinoma
    View official trial listing →
  • Suspended NCT NCT02366819

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

    Not yet reported University of Chicago 36 participants Est. completion 2026-06-08 3 sites Stand-alone
    Other conditions: Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Stage IIB Gastric Cancer, Stage IIIA Esophageal Adenocarcinoma, Stage IIIA Gastric Cancer, Stage IIIB Esophageal Adenocarcinoma, Stage IIIB Gastric Cancer, Stage IIIC Esophageal Adenocarcinoma, Stage IIIC Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT02380131

    Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis

    Not yet reported Hebei Medical University 60 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: HER-2 Positive Gastric Cancer, Liver Metastasis
    View official trial listing →
  • Active, not recruiting NCT NCT02394834

    An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

    Takeda 757 participants Est. completion 2027-09-30 151 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT02404753

    A Comparison of Laparoscopic With Open Distal Gastrectomy in Advanced Gastric Cancer After Neoadjuvant Chemotherapy

    Not yet reported Peking University 102 participants Est. completion 2022-11-25 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT02415829

    Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients

    Not yet reported Fudan University 55 participants 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT02428101

    Oxaliplatin - Induced Peripheral Neuropathy in Patients With Gastrointestinal Tract Cancer

    Ain Shams University 80 participants Est. completion 2024-04 1 site
    Other conditions: Gastrointestinal Tract Cancer, Peripheral Neuropathy
    View official trial listing →
  • Status unknown NCT NCT02452853

    HR Combined With FOLFOX4 for HCC With PVTT

    Not yet reported Sun Yat-sen University 51 participants Est. completion 2018-05 Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT02506842

    Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection

    Not yet reported Fudan University 300 participants Est. completion 2019-06 7 sites Stand-alone
    Other conditions: Stage ⅠA Pancreatic Cancer, Stage ⅠB Pancreatic Cancer, Stage ⅡA Pancreatic Cancer, Stage ⅡB Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT02515734

    A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab

    Not yet reported Japan Clinical Cancer Research Organization 360 participants Est. completion 2020-06 Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02528110

    Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer

    Not yet reported Wuhan University 100 participants Est. completion 2020-03-10 1 site Stand-alone
    Other conditions: Malignant Neoplasm of Stomach
    View official trial listing →
  • Completed NCT NCT02539537

    A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

    Not yet reported UNICANCER 171 participants Est. completion 2023-09-25 45 sites Stand-alone
    Other conditions: Pancreatic Cancer, Carcinoma
    View official trial listing →
  • Completed NCT NCT02545504

    Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

    Not yet reported Gilead Sciences 432 participants Est. completion 2019-05-15 134 sites Stand-alone
    Other conditions: Gastric Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02578732

    FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

    Not yet reported Brown University 28 participants Est. completion 2022-03-16 1 site Stand-alone
    Other conditions: Locally Advanced Pancreatic Cancer, Pancreatic Cancer
    View official trial listing →
  • Withdrawn NCT NCT02580253

    Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation

    Not yet reported Zhejiang University Est. completion 2018-12 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT02582970

    A Study of Bevacizumab (Avastin) in Combination With Chemotherapy in Participants With Metastatic Cancer of the Colon or Rectum

    Not yet reported Hoffmann-La Roche 40 participants Est. completion 2008-04 8 sites Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT02585479

    Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma

    Not yet reported, Not yet reported Guangxi Medical University Est. completion 2017-10 Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT02605265

    Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1

    Not yet reported Fudan University 356 participants Est. completion 2023-06 1 site Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT02654639

    Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer

    Not yet reported Georgetown University 4 participants Est. completion 2017-11 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02715531

    A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors

    Not yet reported Hoffmann-La Roche 243 participants Est. completion 2021-05-31 30 sites Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Completed NCT NCT02730546

    Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery

    Not yet reported, Not yet reported Mayo Clinic 31 participants Est. completion 2023-10-31 2 sites Stand-alone
    Other conditions: Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stage IB Gastric Cancer AJCC v7, Stage II Gastric Cancer AJCC v7, Stage IIA Gastric Cancer AJCC v7, Stage IIB Gastric Cancer AJCC v7, Stage IIIA Gastric Cancer AJCC v7, Stage IIIB Gastric Cancer AJCC v7
    View official trial listing →
  • Terminated NCT NCT02808091

    Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma

    Not yet reported National Cancer Centre, Singapore 7 participants Est. completion 2014-03 1 site
    Other conditions: Extranodal NK-T-CELL LYMPHOMA
    View official trial listing →
  • Status unknown NCT NCT02836847

    Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

    Not yet reported Shanghai Jiao Tong University School of Medicine 152 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer
    View official trial listing →
  • Status unknown NCT NCT02836977

    Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 400 participants Est. completion 2024-02-29 1 site
    Other conditions: Stage III Colon Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT02843191

    Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

    Not yet reported Kyung Hee University Hospital at Gangdong 358 participants Est. completion 2026-06-30 14 sites Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT02848443

    Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer

    Not yet reported Institut de Recherches Internationales Servier 78 participants Est. completion 2020-04-09 24 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Withdrawn NCT NCT02856867

    Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC
    Other conditions: Esophagogastric Adenocarcinoma, Metastatic Disease, No Previous Chemotherapy for Metastatic Esophagogastric Cancer
    View official trial listing →
  • Completed NCT NCT02864849

    Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

    Not yet reported Peking University Cancer Hospital & Institute 81 participants Est. completion 2019-06 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT02870153

    SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

    Not yet reported The First People's Hospital of Changzhou 60 participants Est. completion 2019-06 1 site Stand-alone
    Other conditions: Colorectal Neoplasm
    View official trial listing →
  • Active, not recruiting NCT NCT02912559

    Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

    Not yet reported National Cancer Institute (NCI) 712 participants Est. completion 2026-12-18 1049 sites Stand-alone
    Other conditions: Colon Adenocarcinoma, DNA Repair Disorder, Lynch Syndrome, Stage III Colon Cancer AJCC v8
    View official trial listing →
  • Active, not recruiting NCT NCT02931890

    Multicentric Randomised Trial for Resectable Gastric Cancer

    Not yet reported The Netherlands Cancer Institute 207 participants Est. completion 2029-03 28 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Terminated NCT NCT02953509

    Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

    Not yet reported, Not yet reported Gilead Sciences 178 participants Est. completion 2024-03-25 20 sites Stand-alone
    Other conditions: Non Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT02969681

    Vitamin C Intravenously With Chemotherapy in Advanced Colorectal Cancer

    Not yet reported Sun Yat-sen University 442 participants Est. completion 2020-12-30 1 site Stand-alone
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT02980510

    Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients

    Not yet reported UNICANCER 219 participants Est. completion 2026-01 6 sites Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT03045770

    mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA

    Not yet reported Fujian Cancer Hospital 150 participants Est. completion 2019-12-30 1 site Stand-alone
    Other conditions: Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
    View official trial listing →
  • Completed NCT NCT03065478

    Observational STudy to Evaluate the EFfectiveness of OnLife® in Improving CIPN in Patients With Colon or Breast Cancer After End of Adj. Therapy

    Swiss Medical Food AG 150 participants Est. completion 2018-07 1 site
    Other conditions: CIPN in Adjuvant Colon Cancer Patients, CIPN in Adjuvant Breast Cancer Patients
    View official trial listing →
  • Completed NCT NCT03084809

    Chemotherapy Combined With CIK Treating Colon Cancer

    Not yet reported China Meitan General Hospital 46 participants Est. completion 2014-09-15 Stand-alone
    Other conditions: Colorectal Cancer, Cytokine-induced Killer Cells, Postoperative Complications, Survival
    View official trial listing →
  • Completed NCT NCT03085992

    Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer

    Not yet reported Azienda Ospedaliero, Universitaria Pisana 49 participants Est. completion 2018-03-12 4 sites Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT03126071

    Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

    Not yet reported Jiangsu Cancer Institute & Hospital 100 participants Est. completion 2023-02-15 4 sites Stand-alone
    Other conditions: Advanced Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03164382

    Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma

    Not yet reported Sun Yat-sen University 262 participants Est. completion 2020-11-30 1 site Stand-alone
    Other conditions: Liver Cancer, Hepatic Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03169738

    QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Withdrawn NCT NCT03169777

    QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03174405

    Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial.

    Not yet reported AIO-Studien-gGmbH 43 participants Est. completion 2021-07-16 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03186326

    Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer

    Not yet reported Federation Francophone de Cancerologie Digestive 132 participants Est. completion 2025-03-01 120 sites
    Other conditions: Metastatic Colorectal Cancer, MSI
    View official trial listing →
  • Status unknown NCT NCT03192644

    The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

    Not yet reported Sun Yat-sen University 162 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03197584

    QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy

    Not yet reported, Not yet reported ImmunityBio, Inc. Est. completion 2021-12-28 Stand-alone
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Terminated NCT NCT03203525

    Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

    Not yet reported M.D. Anderson Cancer Center 38 participants Est. completion 2026-07-22 1 site Stand-alone
    Other conditions: Advanced Malignant Neoplasm, Colorectal Carcinoma Metastatic in the Liver, Metastatic Malignant Neoplasm in the Liver, Refractory Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT03213444

    Impact of Adjuvant Chemotherapy in Patients With Colon Cancer

    Not yet reported University of Sao Paulo General Hospital 30 participants Est. completion 2019-02 1 site
    Other conditions: Colon Cancer, Adjuvant Chemotherapy
    View official trial listing →
  • Status unknown NCT NCT03237507

    Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer

    Harbin Medical University 110 participants Est. completion 2020-06-01 1 site
    Other conditions: Stage IV Gastric Cancer With Metastasis
    View official trial listing →
  • Completed NCT NCT03238404

    Neoadjuvant Chemotherapy for Patients With Advanced Gastric Cancer in ERAS Programs for Radical Gastrectomy

    Not yet reported JIANG Zhi-Wei 88 participants Est. completion 2016-12-20 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT03250832

    Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors

    Not yet reported Tesaro, Inc. 111 participants Est. completion 2023-02-13 12 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Suspended NCT NCT03253575

    CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2

    Mitra RxDx, Inc. 800 participants Est. completion 2019-12-15 30 sites
    Other conditions: Adult Solid Tumor
    View official trial listing →
  • Completed NCT NCT03279237

    A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers

    Not yet reported Massachusetts General Hospital 25 participants Est. completion 2026-04-01 1 site Stand-alone
    Other conditions: GastroEsophageal Cancer
    View official trial listing →
  • Terminated NCT NCT03311750

    Anti-EGFR Therapy Rechallenge in Combination With Chemotherapy in Patients With Advanced Colorectal Cancer

    Not yet reported Hellenic Cooperative Oncology Group 23 participants Est. completion 2021-05-20 8 sites Stand-alone
    Other conditions: Advanced Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03362177

    Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

    Not yet reported Amgen 165 participants Est. completion 2025-01-09 117 sites
    Other conditions: Chemotherapy-induced Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT03364907

    Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal Chemotherapy

    Radboud University Medical Center 20 participants Est. completion 2019-12-30 1 site
    Other conditions: Peritoneal Carcinomatosis
    View official trial listing →
  • Terminated NCT NCT03368859

    A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab

    Not yet reported AbbVie 70 participants Est. completion 2019-12-18 65 sites
    Other conditions: Cancer
    View official trial listing →
  • Withdrawn NCT NCT03374852

    CPI-613 in Combination With Modified FOLFIRINOX in Patients With Locally Advanced Pancreatic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2020-10 Stand-alone
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT03377842

    Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer

    Not yet reported Sichuan Provincial People's Hospital 100 participants Est. completion 2020-09-01
    Other conditions: Colorectal Cancer, Neoadjuvant Therapy
    View official trial listing →
  • Terminated NCT NCT03426371

    Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial

    Not yet reported Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 52 participants Est. completion 2021-11-27 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03478488

    Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC

    Not yet reported 3D Medicines (Sichuan) Co., Ltd. 472 participants Est. completion 2024-09-10 1 site Stand-alone
    Other conditions: Biliary Tract Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT03483038

    A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma

    Not yet reported University of Florida 45 participants Est. completion 2026-12 4 sites Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT03504397

    A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

    Not yet reported Astellas Pharma Global Development, Inc. 565 participants Est. completion 2026-09-30 220 sites Stand-alone
    Other conditions: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
    View official trial listing →
  • Withdrawn NCT NCT03536182

    Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2023-07-01 2 sites
    Other conditions: Locally Advanced Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT03565029

    Total Neoadjuvant Treatment Without Surgery For Locally Advanced Rectal Cancer

    Not yet reported Niguarda Hospital 180 participants Est. completion 2023-12-20 1 site Stand-alone
    Other conditions: Colo-rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT03567629

    Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer

    Not yet reported Peking University 130 participants Est. completion 2023-12-30 1 site
    Other conditions: mCRC
    View official trial listing →
  • Completed NCT NCT03578874

    SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC

    Not yet reported The University of Hong Kong 15 participants Est. completion 2019-04-30 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT03584711

    FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation

    Not yet reported Federation Francophone de Cancerologie Digestive 118 participants Est. completion 2025-03-30 124 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT03603834

    Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma

    Not yet reported Khon Kaen University 25 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Cholangiocarcinoma
    View official trial listing →
  • Status unknown NCT NCT03604614

    Hyperthermic Intraperitoneal Chemotherapy for Advanced Gastric Cancer With Peritoneal Metastatis

    Not yet reported Guangdong Provincial Hospital of Traditional Chinese Medicine 56 participants Est. completion 2020-08-24 1 site Stand-alone
    Other conditions: Stage IV Gastric Cancer With Metastasis, Hyperthermic Intraperitoneal Chemotherapy, Exploratory Behavior
    View official trial listing →
  • Completed NCT NCT03611556

    MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.

    Not yet reported, Not yet reported MedImmune LLC 213 participants Est. completion 2022-07-22 27 sites Stand-alone
    Other conditions: Carcinoma, Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT03615326

    Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

    Not yet reported Merck Sharp & Dohme LLC 738 participants Est. completion 2025-11-12 192 sites Stand-alone
    Other conditions: Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT03618758

    Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6

    Not yet reported, Not yet reported Seoul National University Bundang Hospital 35 participants Est. completion 2023-12-02 1 site Stand-alone
    Other conditions: Gastric Cancer Stage IV, Peritoneal Carcinomatosis, Intraperitoneal Paclitaxel, mFOLFOX6
    View official trial listing →
  • Terminated NCT NCT03645876

    SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 12 participants Est. completion 2019-04-18 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03666442

    Early Evaluation of Chemosensitivity for Low/Intermediated-risk Mid-low Stage II/III Rectal Cancer

    Not yet reported West China Hospital 61 participants Est. completion 2022-01-01 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT03678428

    FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM

    Not yet reported Sun Yat-sen University 92 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer, Liver Metastases
    View official trial listing →
  • Status unknown NCT NCT03702491

    Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma

    Not yet reported Eastern Hepatobiliary Surgery Hospital 138 participants Est. completion 2020-08-10 1 site Stand-alone
    Other conditions: Gallbladder Carcinoma
    View official trial listing →
  • Completed NCT NCT03726021

    Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

    Not yet reported Qingdao Central Hospital 47 participants Est. completion 2023-02-28 1 site Stand-alone
    Other conditions: Overall Survival
    View official trial listing →
  • Active, not recruiting NCT NCT03764553

    Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 320 participants Est. completion 2026-12-01 34 sites Stand-alone
    Other conditions: Esophageal Cancer
    View official trial listing →
  • Status unknown NCT NCT03771846

    HAIC Versus Systemic Chemotherapy for Unresectable ICC

    Not yet reported Shi Ming 188 participants Est. completion 2022-08-01 2 sites Stand-alone
    Other conditions: Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT03778593

    FOLFIRINOX for 2nd-line Treatment of BTC

    Not yet reported Dong-A University Hospital 34 participants Est. completion 2021-01-14 1 site Stand-alone
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Completed NCT NCT03813784

    A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 885 participants Est. completion 2023-06-07 1 site Stand-alone
    Other conditions: Gastric Cancer, GastroEsophageal Cancer
    View official trial listing →
  • Status unknown NCT NCT03868228

    PIPAC for the Treatment of Colorectal Peritoneal Metastases

    Not yet reported, Not yet reported Imperial College London 30 participants Est. completion 2024-09-30 1 site Stand-alone
    Other conditions: Colorectal Neoplasms, Peritoneal Metastases
    View official trial listing →
  • Terminated NCT NCT03875313

    Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors

    Not yet reported, Not yet reported Calithera Biosciences, Inc 33 participants Est. completion 2020-07-29 9 sites Stand-alone
    Other conditions: Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer, Colorectal Cancer, CRC, RCC, ccRCC
    View official trial listing →
  • Status unknown NCT NCT03950154

    Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 198 participants Est. completion 2023-08-01 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03950271

    SHR-1210 Combined With Trastuzumab , Oxaliplatin and Capecitabine for Neoadjuvant Therapy of Gastric Adenocarcinoma/Gastroesophageal Junction Adenocarcinoma

    Not yet reported Henan Cancer Hospital 25 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Withdrawn NCT NCT03982121

    Study of Intratumoral Ipilimumab and TLR4 Agonist GLA-SE in Combination With Systemic Nivolumab and Chemotherapy

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris Est. completion 2020-02-12 1 site Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT03983057

    Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer

    Not yet reported Zhejiang University 392 participants Est. completion 2025-11-25 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT03986385

    Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Gastroesophageal Junction

    Not yet reported Hebei Medical University 180 participants Est. completion 2021-01-31 1 site Stand-alone
    Other conditions: Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04010552

    Nalirinox Neo-pancreas RAS Mut ctDNA Study

    Not yet reported Fundación de investigación HM 20 participants Est. completion 2023-11 3 sites Stand-alone
    Other conditions: Resectable Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT04047862

    Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

    Not yet reported BeiGene 446 participants Est. completion 2024-08-07 65 sites Stand-alone
    Other conditions: Locally Advanced and Metastatic Solid Tumors
    View official trial listing →
  • Status unknown NCT NCT04060472

    Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors

    Not yet reported, Not yet reported Dong Wang 57 participants Est. completion 2023-10-20 Stand-alone
    Other conditions: Advanced Hepatobiliary and Malignant Tumors
    View official trial listing →
  • Status unknown NCT NCT04062058

    A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer

    Not yet reported Jing Jin, M.D. 82 participants Est. completion 2023-09-21 1 site Stand-alone
    Other conditions: Gastric Cancer, Neoadjuvant Therapy
    View official trial listing →
  • Active, not recruiting NCT NCT04094688

    Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 455 participants Est. completion 2026-07-01 1031 sites Stand-alone
    Other conditions: Colorectal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04097444

    CAPOXIRI+Bevacizumab vs. FOLFOXIRI+Bevacizumab for mCRC

    Not yet reported Chugai Pharmaceutical 112 participants Est. completion 2022-08-31 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04117945

    Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer

    Not yet reported Academic and Community Cancer Research United 22 participants Est. completion 2025-03-31 15 sites
    Other conditions: BRAF V600E Negative, KRAS Gene Mutation Negative, Locally Advanced Unresectable Colorectal Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, NRAS Gene Mutation Negative, Stage III Colorectal Cancer AJCC v8, Stage IIIA Colorectal Cancer AJCC v8, Stage IIIB Colorectal Cancer AJCC v8, Stage IIIC Colorectal Cancer AJCC v8, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
    View official trial listing →
  • Completed NCT NCT04130854

    INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

    Not yet reported University of Texas Southwestern Medical Center 58 participants Est. completion 2026-01-30 4 sites Stand-alone
    Other conditions: Locally Advanced Rectal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04170530

    Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer

    Not yet reported First Affiliated Hospital of Zhejiang University 51 participants Est. completion 2022-01-01 1 site Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04185883

    Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

    Not yet reported Amgen 610 participants Est. completion 2027-12-05 90 sites Stand-alone
    Other conditions: Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation
    View official trial listing →
  • Completed NCT NCT04217954

    HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC

    Not yet reported Peking University 32 participants Est. completion 2023-06-01 1 site Stand-alone
    Other conditions: Advanced Biliary Tract Cancer
    View official trial listing →
  • Completed NCT NCT04224402

    Efficacy and Safety of mFOLFIRINOX as Postoperative Chemotherapy for Pancreatic Cancer in Chinese Patients.

    Not yet reported Yuhong Li 80 participants Est. completion 2022-12-31 1 site
    Other conditions: Pancreatic Cancer Resectable
    View official trial listing →
  • Completed NCT NCT04229004

    A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

    Not yet reported Pancreatic Cancer Action Network 502 participants Est. completion 2025-02-05 25 sites
    Other conditions: Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT04230187

    Bevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal Cancer

    Not yet reported Yanhong Deng 528 participants Est. completion 2029-06-01 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04262687

    Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate

    Not yet reported Federation Francophone de Cancerologie Digestive 55 participants Est. completion 2024-09-30 88 sites Stand-alone
    Obstructive sleep apnea Other conditions: Colorectal Cancer Metastatic, High Immune Infiltrate
    View official trial listing →
  • Status unknown NCT NCT04301557

    PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

    Not yet reported Sun Yat-sen University 25 participants Est. completion 2024-12-30 1 site Stand-alone
    Other conditions: DMMR Colorectal Cancer, MSI-H Colorectal Cancer, Locally Advanced Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04342936

    Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 56 participants Est. completion 2023-12-01 1 site
    Other conditions: Classical Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04393584

    FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

    Not yet reported, Not yet reported Blokhin's Russian Cancer Research Center 538 participants Est. completion 2026-01-01 1 site Stand-alone
    Other conditions: Stomach Neoplasms, Gastrointestinal Neoplasms, Docetaxel, Oxaliplatin, Fluoruracil, Irinotecan Hydrochloride
    View official trial listing →
  • Withdrawn NCT NCT04398927

    Systemic Chemotherapy Plus PD-1 for Metastasis ICC

    Not yet reported Sun Yat-sen University Est. completion 2021-02-01 1 site Stand-alone
    Other conditions: ICC, Metastatic Cancer
    View official trial listing →
  • Status unknown NCT NCT04416854

    The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer

    Not yet reported Fudan University 627 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Metastatic Colon Cancer, Surgery
    View official trial listing →
  • Withdrawn NCT NCT04418895

    Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

    Not yet reported UNC Lineberger Comprehensive Cancer Center Est. completion 2025-05 1 site Stand-alone
    Other conditions: Rectal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04423965

    A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

    Not yet reported First Affiliated Hospital of Zhejiang University 220 participants Est. completion 2025-05-01 1 site Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Terminated NCT NCT04425070

    A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma

    Not yet reported, Not yet reported Antengene Corporation 56 participants Est. completion 2025-12-30 13 sites Stand-alone
    Other conditions: Peripheral T-cell Lymphoma, NK/T-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT04469556

    Pancreatic Adenocarcinoma Signature Stratification for Treatment

    Not yet reported University Health Network, Toronto 150 participants Est. completion 2025-03-05 6 sites
    Other conditions: Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Advanced Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT04506281

    PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

    Not yet reported Shanghai Zhongshan Hospital 128 participants Est. completion 2023-08 1 site Stand-alone
    Other conditions: Cholangiocarcinoma, Intrahepatic
    View official trial listing →
  • Completed NCT NCT04510064

    Conversion Effects of PD-1 Antibody Camrelizumab Combined With Nab-POF Regimen Chemotherpy in Patients With Initially Unresectable Locally Advanced or Limited Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma：FDZL-GC001 Trial

    Not yet reported Fudan University 40 participants Est. completion 2024-07-31 1 site Stand-alone
    Other conditions: Metastatic Gastric Cancer, Locally Advanced Gastric Adenocarcinoma, Gastric Cancer Adenocarcinoma Metastatic
    View official trial listing →
  • Completed NCT NCT04513951

    AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients

    Not yet reported Gruppo Oncologico del Nord-Ovest 62 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04543695

    A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 255 participants Est. completion 2025-06-01 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04582591

    Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy

    Not yet reported Zealand University Hospital 54 participants Est. completion 2023-08-30 1 site
    Other conditions: Chemotherapy-induced Peripheral Neuropathy
    View official trial listing →
  • Terminated NCT NCT04583488

    Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

    Not yet reported Johns Hopkins University 2 participants Est. completion 2024-08-06 1 site
    Other conditions: Peritoneal Carcinomatosis
    View official trial listing →
  • Active, not recruiting NCT NCT04592913

    Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer

    Not yet reported AstraZeneca 957 participants Est. completion 2027-09-27 156 sites Stand-alone
    Other conditions: Gastrointestinal Neoplasms, Esophagogastric Junction
    View official trial listing →
  • Status unknown NCT NCT04611724

    A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer

    Not yet reported Asan Medical Center 35 participants Est. completion 2024-09-30 1 site Stand-alone
    Other conditions: Urachal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04624958

    Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCL

    Not yet reported Sun Yat-sen University 42 participants Est. completion 2026-12 3 sites Stand-alone
    Other conditions: Mantle Cell Lymphoma, Newly-diagnosed Mantle Cell Lymphoma
    View official trial listing →
  • Suspended NCT NCT04668365

    Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

    Not yet reported Henan Cancer Hospital 59 participants Est. completion 2025-12-25 1 site Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation
    View official trial listing →
  • Withdrawn NCT NCT04682249

    Systemic Chemotherapy, Apatinib Plus Sintilimab for Metastasis ICC

    Not yet reported Sun Yat-sen University Est. completion 2021-02-01 1 site Stand-alone
    Other conditions: ICC
    View official trial listing →
  • Status unknown NCT NCT04699994

    Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel

    Not yet reported Keio University 60 participants Est. completion 2024-10-31 1 site
    Other conditions: Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT04747951

    Total Neoadjuvant Therapy in Rectal Cancer Treatment

    Not yet reported State Scientific Centre of Coloproctology, Russian Federation 280 participants Est. completion 2023-11-01 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT04761614

    Riluzole in Combination With mFOLFOX6 and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

    Not yet reported Ning Jin 13 participants Est. completion 2023-05-06 1 site Stand-alone
    Other conditions: Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8, Stage IVB Colorectal Cancer AJCC v8, Stage IVC Colorectal Cancer AJCC v8
    View official trial listing →
  • Status unknown NCT NCT04782791

    Nivolumab, S-1 Combined With Oxaliplatin Versus Nivolumab as Neoadjuvant Therapy in Advanced Gastric Cancer

    Not yet reported Chinese PLA General Hospital 30 participants Est. completion 2024-05-31 Stand-alone
    Other conditions: Gastric Cancer, Chemotherapy Effect
    View official trial listing →
  • Active, not recruiting NCT NCT04793932

    Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL)

    Not yet reported Associazione Italiana per lo Studio del Pancreas 261 participants Est. completion 2026-01-31 22 sites
    Other conditions: Pancreas Ductal Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04835064

    Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

    Not yet reported Fudan University 600 participants Est. completion 2024-12-01 Stand-alone
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT04850040

    A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and Oxaliplatin

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 15 participants Est. completion 2024-12-31 Stand-alone
    Other conditions: Hepatocellular Carcinoma Resectable
    View official trial listing →
  • Withdrawn NCT NCT04859582

    Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension

    Not yet reported Merck Sharp & Dohme LLC Est. completion 2024-11-29 28 sites Stand-alone
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Status unknown NCT NCT04913662

    Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel in Gastric Cancer Patients With Peritoneal Metastasis

    Not yet reported Seoul National University Bundang Hospital 18 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: Stomach Neoplasm, Peritoneal Metastases
    View official trial listing →
  • Active, not recruiting NCT NCT04928807

    Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

    Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 231 participants Est. completion 2028-03-20 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT04994236

    Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy

    Not yet reported Hui-Chuan Sun 49 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05022030

    First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes

    Not yet reported West China Hospital 150 participants Est. completion 2026-06-01 1 site Stand-alone
    Other conditions: Colo-rectal Cancer, Capecitabine, Cetuximab
    View official trial listing →
  • Status unknown NCT NCT05024812

    Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

    Not yet reported, Not yet reported The First Affiliated Hospital of Zhengzhou University 64 participants Est. completion 2025-02 1 site Stand-alone
    Other conditions: Metastatic Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT05029973

    HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2023-11-10 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05074966

    The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

    Not yet reported Chinese Academy of Medical Sciences 314 participants Est. completion 2025-06-24 1 site Stand-alone
    Other conditions: Colo-rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT05077839

    Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 184 participants Est. completion 2025-08-31 1 site Stand-alone
    Other conditions: First-line Treatment, Advanced Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT05111860

    Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy

    Not yet reported, Not yet reported Shanghai Minimally Invasive Surgery Center 20 participants Est. completion 2025-08-01 1 site Stand-alone
    Other conditions: Neoadjuvant Treatment, Rectal Cancer, Bevacizumab, Radiotherapy
    View official trial listing →
  • Completed NCT NCT05116891

    A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors

    Not yet reported, Not yet reported Cantargia AB 40 participants Est. completion 2023-06-23 6 sites
    Other conditions: Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer, Biliary Tract Cancer
    View official trial listing →
  • Status unknown NCT NCT05122091

    Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma

    Not yet reported Guangxi Medical University 53 participants Est. completion 2024-11-30 1 site Stand-alone
    Other conditions: Gastric Cancer, GastroEsophageal Cancer, Fruquintinib, SOX
    View official trial listing →
  • Active, not recruiting NCT NCT05141721

    A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Seattle Project Corporation 700 participants Est. completion 2027-03 43 sites Stand-alone
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Status unknown NCT NCT05166772

    Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2024-12 Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Terminated NCT NCT05171166

    Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.

    Not yet reported, Not yet reported Peking University 18 participants Est. completion 2025-10-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05186558

    Penpulimab Plus R2-GemOx Regimen in Relapsed or Refractory DLBCL

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 54 participants Est. completion 2026-02-15 4 sites Stand-alone
    Other conditions: Lymphoma, Large B-Cell, Diffuse, Neoplasms by Histologic Type
    View official trial listing →
  • Active, not recruiting NCT NCT05198609

    Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

    Not yet reported Sun Yat-sen University 214 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05198856

    Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC

    Not yet reported, Not yet reported Qilu Hospital of Shandong University 106 participants Est. completion 2024-12-10 Stand-alone
    Other conditions: Gastric Cancer Metastatic to Liver
    View official trial listing →
  • Active, not recruiting NCT NCT05212012

    D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer

    Not yet reported, Not yet reported AIO-Studien-gGmbH 11 participants Est. completion 2025-12 3 sites Stand-alone
    Other conditions: Chemo-refractory Colorectal Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05215665

    GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 146 participants Est. completion 2026-01-15 1 site Stand-alone
    Other conditions: Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT05254639

    Donepezil for Oxaliplatin-induced Neuropathy Peripheral Neuropathy: Proof of Concept Study

    Not yet reported University Hospital, Clermont-Ferrand 77 participants Est. completion 2024-01-24 34 sites
    Other conditions: Digestive Oncology, Supportive Care
    View official trial listing →
  • Completed NCT NCT05268510

    Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma

    Not yet reported Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 31 participants Est. completion 2025-01-09 1 site Stand-alone
    Other conditions: Esophagogastric Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05290116

    HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma

    Not yet reported Yunfei Yuan 17 participants Est. completion 2023-09-01 1 site Stand-alone
    Other conditions: Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05346874

    Neoadjuvant TACiE in Locally Advanced Gastric Cancer

    Not yet reported Shanghai Zhongshan Hospital 37 participants Est. completion 2025-05-01 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT05381506

    Study of Orelabrutinib in Combination With Gemox in Refractory / Relapsed Diffuse Large B-cell Lymphoma

    Not yet reported Sun Yat-sen University 77 participants Est. completion 2025-12 8 sites Stand-alone
    Other conditions: DLBCL
    View official trial listing →
  • Terminated NCT NCT05417386

    FOLFIRINOX + NIS793 in Pancreatic Cancer

    Not yet reported Colin D. Weekes, M.D., PhD 4 participants Est. completion 2023-07-10 1 site Stand-alone
    Other conditions: Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT05468138

    PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

    Not yet reported Fudan University 94 participants Est. completion 2029-02-28 1 site
    Other conditions: MSI-H, PD-1 Immunotherapy, Gastric Cancer, Adjuvant Therapy
    View official trial listing →
  • Status unknown NCT NCT05493332

    HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 93 participants Est. completion 2024-09 Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05494320

    the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

    Ain Shams University 120 participants Est. completion 2022-12-31 1 site
    Other conditions: Gastrointestinal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT05502393

    A Clinical Study to Evaluate the Safety and Tolerability of JS107 in Advanced or Metastatic Solid Tumors

    Not yet reported Shanghai Junshi Bioscience Co., Ltd. 133 participants Est. completion 2027-12-31 20 sites Stand-alone
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Status unknown NCT NCT05519202

    Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer

    Not yet reported The Central Hospital of Lishui City 47 participants Est. completion 2024-08-31 Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT05546853

    Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma

    Not yet reported University Hospital, Grenoble 43 participants Est. completion 2025-06-16 9 sites Stand-alone
    Other conditions: Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT05564403

    Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

    Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2026-10-01 207 sites Stand-alone
    Other conditions: Advanced Biliary Tract Carcinoma, Advanced Gallbladder Carcinoma, Advanced Intrahepatic Cholangiocarcinoma, Recurrent Biliary Tract Carcinoma, Recurrent Gallbladder Carcinoma, Recurrent Intrahepatic Cholangiocarcinoma, Stage III Distal Bile Duct Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8, Stage III Hilar Cholangiocarcinoma AJCC v8, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Distal Bile Duct Cancer AJCC v8, Stage IV Gallbladder Cancer AJCC v8, Stage IV Hilar Cholangiocarcinoma AJCC v8, Stage IV Intrahepatic Cholangiocarcinoma AJCC v8, Unresectable Biliary Tract Carcinoma, Unresectable Gallbladder Carcinoma, Unresectable Intrahepatic Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT05568095

    A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body

    Not yet reported Arcus Biosciences, Inc. 1040 participants Est. completion 2026-08-28 168 sites Stand-alone
    Other conditions: Advanced Upper Gastrointestinal Tract Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05580887

    Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients

    Moscow Clinical Scientific Center 35 participants Est. completion 2025-08 1 site
    Other conditions: Breast Cancer, Pancreas Cancer
    View official trial listing →
  • Status unknown NCT NCT05588297

    Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases

    Not yet reported Shanghai Changzheng Hospital 12 participants Est. completion 2025-10 Stand-alone
    Other conditions: Colorectal Cancer Liver Metastases
    View official trial listing →
  • Active, not recruiting NCT NCT05621499

    HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 60 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT05680870

    The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

    Not yet reported Aya Mohamed Sadek Elsaid 46 participants Est. completion 2024-12-12 1 site
    Other conditions: Chemotherapy Induced Peripheral Neuropathy
    View official trial listing →
  • Active, not recruiting NCT NCT05715931

    Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

    Not yet reported Yu jiren 30 participants Est. completion 2028-10-01 8 sites Stand-alone
    Other conditions: Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, HER2-positive Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT05774964

    Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases

    Not yet reported Liaoning Cancer Hospital & Institute 100 participants Est. completion 2025-03-15 1 site Stand-alone
    Other conditions: For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method
    View official trial listing →
  • Status unknown NCT NCT05833815

    Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

    Not yet reported, Not yet reported Banaras Hindu University 56 participants Est. completion 2024-12-30 1 site
    Other conditions: Gallbladder Cancer
    View official trial listing →
  • Status unknown NCT NCT05839197

    A Single-arm Clinical Study of HAIC Combined With Apatinib and Camrelizumab in the Treatment of Unresectable MTM HCC

    Not yet reported Wan-Guang Zhang 38 participants Est. completion 2025-04-15 1 site Stand-alone
    Other conditions: Macrotrabecular Massive Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05858567

    Total Neoadjuvant Therapy With Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Ultra Low Rectal Adenocarcinoma

    Not yet reported Sir Run Run Shaw Hospital 30 participants Est. completion 2025-06-30 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT05864755

    HAIC Combined With Durvalumab, Tremelimumab and Bevacizumab as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 30 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Unrescetable Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05872841

    H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 38 participants Est. completion 2025-06-30 Stand-alone
    Other conditions: Primary Hepatocellular Carcinoma, Portal Vein Thrombosis
    View official trial listing →
  • Completed NCT NCT05908838

    Clinical Study of Modified Banxia Xiexin Decoction Treatment on Gastric Cancer

    Not yet reported ShuGuang Hospital 146 participants Est. completion 2022-12-02
    Other conditions: Gastric Cancer (Diagnosis)
    View official trial listing →
  • Completed NCT NCT05916118

    Exercise and Oxaliplatin-induced Peripheral Neuropathy

    Not yet reported Dartmouth-Hitchcock Medical Center 10 participants Est. completion 2023-06-25 2 sites Stand-alone
    Other conditions: Peripheral Neuropathy
    View official trial listing →
  • Completed NCT NCT05941481

    Neoadjuvant Chemo-hypoRT Plus PD-1 Antibody (Tislelizumab) in Resectable LA-G/GEJ

    Not yet reported Jiangsu Cancer Institute & Hospital 21 participants Est. completion 2026-06-20 1 site Stand-alone
    Other conditions: Gastric or Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05948072

    Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

    Not yet reported Fudan University 250 participants Est. completion 2026-07-15 1 site Stand-alone
    Other conditions: Colorectal Cancer, Liver Metastases
    View official trial listing →
  • Status unknown NCT NCT05964543

    The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

    Not yet reported, Not yet reported QureBio Ltd. 72 participants Est. completion 2025-08-30 1 site Stand-alone
    Other conditions: Gastroesophageal Junction (GEJ) Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT05970627

    Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

    Not yet reported Yu jiren 30 participants Est. completion 2029-07-28 8 sites Stand-alone
    Other conditions: Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma
    View official trial listing →
  • Status unknown NCT NCT05974059

    Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 20 participants Est. completion 2024-08-01 1 site Stand-alone
    Other conditions: Locally Advanced Unresectable Gastric Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT05986227

    The Sequential Combination of FOLFOX and Toripalimab for Perioperative Immuno-Oncology Therapy of HER2-negative Adenocarcinoma of the Esophagogastric Junction (Siewert I/II):

    Not yet reported, Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 126 participants Est. completion 2026-07-01 Stand-alone
    Other conditions: Gastroesophageal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT05997524

    Clinical Efficacy of Trastuzumab in Combination With Capecitabine and Oxaliplatin for the Treatment of HER2-positive Advanced Gastric Cancer.

    Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 60 participants Est. completion 2023-06-30 1 site Stand-alone
    Other conditions: Advanced Gastric Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06033118

    Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC

    Not yet reported, Not yet reported Sichuan University 25 participants Est. completion 2026-08-01 Stand-alone
    Other conditions: Combined Hepatocellular Cholangiocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT06035133

    Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy

    Not yet reported Tang-Du Hospital 213 participants Est. completion 2027-11-10 Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Status unknown NCT NCT06041035

    A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors

    Not yet reported, Not yet reported Qilu Pharmaceutical Co., Ltd. 115 participants Est. completion 2025-10 1 site Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Status unknown NCT NCT06123455

    Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer

    Not yet reported Tang-Du Hospital 60 participants Est. completion 2025-07-31 1 site Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT06134388

    Sulfasalazine in Patients With Metastatic Colorectal Cancer

    Not yet reported Tanta University 50 participants Est. completion 2026-09 1 site
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT06139211

    A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

    Not yet reported, Not yet reported Shanghai Junshi Bioscience Co., Ltd. 66 participants Est. completion 2026-05-28 1 site Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Status unknown NCT NCT06153368

    Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 30 participants Est. completion 2025-11-27 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT06164327

    Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

    Not yet reported BeBetter Med Inc 75 participants Est. completion 2025-11-05 1 site Stand-alone
    Other conditions: Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT06192186

    Adebrelimab Combined With SOX Regimen in Preoperative Neoadjuvant Transformation Therapy for Locally Advanced Gastric Adenocarcinoma

    Not yet reported Yang Jianjun, PhD 110 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Locally Advanced Gastric Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT06199297

    Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

    Sun Yat-sen University 188 participants Est. completion 2023-07-25 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06266871

    SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

    Not yet reported, Not yet reported West China Hospital 64 participants Est. completion 2026-07-30 Stand-alone
    Other conditions: Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT06285019

    Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma

    Not yet reported Fudan University 65 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06329947

    A Phase II Study of Surufatinib Combined With Camrelizumab and mFOLFOX6 as Second-line Treatment for Advanced PRAD

    Not yet reported Rui-hua Xu, MD, PhD 37 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Advanced Pancreatic Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06375317

    HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure

    Not yet reported Yehua Shen 42 participants Est. completion 2026-10-30 Stand-alone
    Other conditions: HCC - Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06443307

    Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan

    Peking University 933 participants Est. completion 2026-08-01 1 site
    Other conditions: Colorectal Cancer, Solid Tumor
    View official trial listing →
  • Status unknown NCT NCT06463444

    Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models

    Not yet reported Chen Xiaoping 30 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: HCC, Precision Therapy
    View official trial listing →
  • Status unknown NCT NCT06516445

    SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC

    Not yet reported Huazhong University of Science and Technology 33 participants Est. completion 2026-06-28 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06540261

    The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer

    Not yet reported Ono Pharmaceutical Co., Ltd. 65 participants Est. completion 2027-12-31 17 sites Stand-alone
    Other conditions: Unresectable Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT06594692

    Node-Sparing Short-Course Radiation With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer: A Randomized, Prospective, Multicenter Study

    Not yet reported Sir Run Run Shaw Hospital 140 participants Est. completion 2026-09-30 2 sites Stand-alone
    Obstructive sleep apnea Other conditions: Locally Advanced Colon Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06654947

    A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer.

    Not yet reported Fujian Cancer Hospital 23 participants Est. completion 2027-12 Stand-alone
    Other conditions: Biliary Tract Cancer
    View official trial listing →
  • Completed NCT NCT06692907

    Efficacy Study of IM Administered CssBA+dmLT Against Moderate-severe Diarrhea in Human Infection Model With ETEC Strain B7A in Healthy Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 72 participants Est. completion 2026-04-01 2 sites
    Other conditions: Escherichia Infection
    View official trial listing →
  • Not yet recruiting NCT NCT06753721

    An Open-label, Multicenter, Single-arm Clinical Study on the Use of Doxorubicin Liposome in Combination With CapOX and Bevacizumab Regimen for First-line Treatment of Advanced Colorectal Adenocarcinoma With SMAD4R361H/C Mutation.

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 13 participants Est. completion 2027-06-01 Stand-alone
    Other conditions: Advanced Colorectal Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT06760520

    Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

    Not yet reported The First Affiliated Hospital of Zhengzhou University 40 participants Est. completion 2031-12-20 Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06766019

    Adebrelimab Combined With Irinotecan Liposomal (II), Oxaliplatin, and 5-FU/LV Conversion Therapy for Locally Advanced Pancreatic Cancer

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 47 participants Est. completion 2027-09-30 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06771622

    Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors

    Not yet reported, Not yet reported FBD Biologics Limited 500 participants Est. completion 2029-01-01 1 site Stand-alone
    Other conditions: Solid Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06839092

    Prophylactic PIPAC in Patients With High-risk Colorectal Cancer

    Not yet reported Jeremy Meyer 160 participants Est. completion 2034-01 Stand-alone
    Other conditions: Colorectal Cancer Control and Prevention, Colorectal Cancer, Colorectal Cancer Stage II, Colorectal Cancer Stage III
    View official trial listing →
  • Not yet recruiting NCT NCT06858969

    Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 130 participants Est. completion 2028-01-08 Stand-alone
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06888037

    Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer

    Not yet reported Ruijin Hospital 55 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Gastric Adenocarcinoma, GEJ Adenocarcinoma, First-line Therapy, Maintenance Therapy, Fruquintinib, PD-1
    View official trial listing →
  • Active, not recruiting NCT NCT06939452

    A Single-arm, Multicenter Exploratory Clinical Trial of Anlotinib Combined With TQB2450 and the SOX Regimen as First-line Treatment for Advanced Gastric Cancer With Low PD-L1 Expression

    Not yet reported Yongxu Jia 37 participants Est. completion 2026-06-01 1 site Stand-alone
    Other conditions: Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT06959693

    A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

    Not yet reported, Not yet reported Sun Yat-sen University 590 participants Est. completion 2030-06-30 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer (CRC)
    View official trial listing →
  • Active, not recruiting NCT NCT06967155

    A Study of Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer

    Not yet reported Blokhin's Russian Cancer Research Center 23 participants Est. completion 2028-06-10 1 site Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT06975917

    Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)

    Ankara University 600 participants Est. completion 2025-05-30 1 site
    Other conditions: Biliary Tract Cancer, Biliary Tract Cancers (BTC)
    View official trial listing →
  • Not yet recruiting NCT NCT07007728

    Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

    Not yet reported Peking University Cancer Hospital & Institute 54 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Colorectal Neoplasms, Secondary Malignant Neoplasm of Liver
    View official trial listing →
  • Not yet recruiting NCT NCT07074353

    Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

    Not yet reported Zhejiang Cancer Hospital 360 participants Est. completion 2030-07-01 1 site Stand-alone
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07118800

    Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old

    Not yet reported UNICANCER 160 participants Est. completion 2032-01-15 Stand-alone
    Other conditions: Locally Advanced Rectal Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07132008

    Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

    Not yet reported First Affiliated Hospital of Guangxi Medical University 94 participants Est. completion 2030-09-30 1 site Stand-alone
    Other conditions: Colonic Neoplasms, Neoadjuvant Therapy, Immune Checkpoint Inhibitors
    View official trial listing →
  • Not yet recruiting NCT NCT07191405

    Clinical Study of Chemotherapy and Immunotherapy Combined With Lactobacillus Johnsonii in Patients With Multiple Irresectable Solid Tumors

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 156 participants Est. completion 2026-12-31 Stand-alone
    Other conditions: Immunotherapy, Chemotherapy
    View official trial listing →
  • Completed NCT NCT07196631

    Comparison of Liposomal Bupivacaine Versus Ropivacaine in Alleviating Rebound Pain

    Not yet reported Liu Jiuhong 100 participants Est. completion 2026-01-02 1 site
    Other conditions: Rebound Pain, Liposomal Bupivacaine
    View official trial listing →
  • Not yet recruiting NCT NCT07277842

    PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

    Not yet reported Sun Yat-sen University 382 participants Est. completion 2028-12-29 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Locally Advanced Low Rectal Adenocarcinoma
    View official trial listing →
  • Enrolling by invitation NCT NCT07334587

    Comparison of Efficacy and Safety Between FOLFOX-6 and CAPOX in Metastatic Colorectal Carcinoma

    Not yet reported Allama Iqbal Medical College 248 participants Est. completion 2026-02-28 1 site Stand-alone
    Other conditions: Metastatic Colorectal Carcinoma (mCRC)
    View official trial listing →
  • Not yet recruiting NCT NCT07353827

    FOLFOX-HAIC Combined With Donafenib and Pucotenlimab as First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma

    Not yet reported Sun Yat-sen University 36 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Intrahepatic Cholangiocarcinoma (Icc), Hepatic Arterial Infusion Chemotherapy
    View official trial listing →
  • Not yet recruiting NCT NCT07381777

    XELOX Plus DoSTARlimab Versus XELOX Alone as Consolidation Treatment After Standard Chemoradiation in pMMR/MSS or MSI-Low Locally Advanced Rectal Cancer (LARC) Patients

    Not yet reported Gruppo Oncologico Italiano di Ricerca Clinica 270 participants Est. completion 2030-12-31 30 sites Stand-alone
    Other conditions: Locally Advanced Rectal Cancer (LARC)
    View official trial listing →
  • Not yet recruiting NCT NCT07384377

    JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan

    Not yet reported Shanghai JMT-Bio Inc. 123 participants Est. completion 2028-06-15
    Other conditions: HER2-positive Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT07391163

    Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer

    Not yet reported Tanta University 46 participants Est. completion 2026-01-01 1 site Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07449780

    A Study of AK104 (SC) in Combination With Oxaliplatin and Capecitabine (XELOX) Versus AK104 (IV) in Combination With XELOX in Participants With Unresectable Locally Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

    Not yet reported Akeso 422 participants Est. completion 2028-02-15 Stand-alone
    Other conditions: Gastric / Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07453394

    QLS5132 Combination Therapy in Advanced Solid Tumors

    Not yet reported, Not yet reported Qilu Pharmaceutical Co., Ltd. 626 participants Est. completion 2029-02 Stand-alone
    Other conditions: Gastric Cancer (GC), Non-small Cell Lung Cancer (NSCLC), Endometrial Cancer, Advanced Solid Tumors, Ovarian Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07480382

    Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC

    Not yet reported Hong Wu 30 participants Est. completion 2028-06-30 1 site Stand-alone
    Other conditions: Initially Unresectable Hepatocellular Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07503639

    Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

    Not yet reported Fudan University 134 participants Est. completion 2030-04 Stand-alone
    Other conditions: Locally Advanced Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT07529613

    Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma

    Not yet reported, Not yet reported National Cancer Center Hospital East 30 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07549906

    Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study

    Not yet reported Sun Yat-sen University 45 participants Est. completion 2026-12-31 Stand-alone
    Other conditions: Colon Cancer (Stage II &Amp; III), Immunotherapy, Beta Blocker, Neoadjuvant Chemoimmunotherapy
    View official trial listing →
  • Not yet recruiting NCT NCT07554482

    Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma

    Not yet reported Beijing Tongren Hospital 34 participants Est. completion 2029-04-30 1 site Stand-alone
    Other conditions: Extranodal NK/T-cell Lymphoma
    View official trial listing →
  • Not yet recruiting NCT NCT07618546

    A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence Factors

    Not yet reported Henan Cancer Hospital 208 participants Est. completion 2028-03-31 Stand-alone
    Other conditions: HCC - Hepatocellular Carcinoma
    View official trial listing →
  • Not yet recruiting NCT NCT07621497

    FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)

    Not yet reported Sun Yat-sen University 229 participants Est. completion 2030-06-01 1 site Stand-alone
    Other conditions: Metastatic Colorectal Cancer (CRC)
    View official trial listing →
  • Not yet recruiting NCT NCT07680569

    Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma

    Not yet reported, Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 40 participants Est. completion 2027-12 Stand-alone
    Other conditions: GC/GEJC
    View official trial listing →
  • Not yet recruiting NCT NCT07737600

    A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer

    Not yet reported, Not yet reported Lepu Biopharma Co., Ltd. 316 participants Est. completion 2029-12 1 site Stand-alone
    Other conditions: Advanced Colorectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07750041

    A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal Cancer

    Not yet reported, Not yet reported CSPC Megalith Biopharmaceutical Co.,Ltd. 260 participants Est. completion 2029-08-30 1 site Stand-alone
    Other conditions: Unresectable Advanced or Metastatic Colorectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07765667

    NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC

    Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 100 participants Est. completion 2029-09-01 1 site Stand-alone
    Other conditions: Rectal Adenocarcinoma, High-Risk Cancer, MSS
    View official trial listing →
  • Not yet recruiting NCT NCT07810114

    Total Neoadjuvant mFOLFOX6 Plus Suvemcitug and Enlonstobart With Selective Omission of Pelvic Radiotherapy for High-Risk Mid-Rectal Locally Advanced Rectal Cancer

    Not yet reported Fudan University 52 participants Est. completion 2030-12-01 1 site Stand-alone
    Other conditions: Rectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07844057

    First-line Treatment in Locally Advanced or Metastastic Small Bowel Adenocarcinoma

    Not yet reported Annika Kurreck 86 participants Est. completion 2034-04-01 16 sites
    Other conditions: Small-bowel Adenocarcinoma, Metastatic Disease, Chemotherapy Effect
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Oxaliplatin, 1-OHP, Ai Heng, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, Elplat, JM 83, Oxalatoplatin, Oxalatoplatinum, RP 54780, SR 96669

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.